Skip to main content

 Biosimilar for Patients on Denosumab

 Biosimilar for Patients on Denosumab

Original Air Date : October 24, 2024

Original Air Date : October 24, 2024

This webinar will provide you with information about the recently approved biosimilar for denosumab by Health Canada.

Join Dr. Teri Charrois who will discuss what a biologic and biosimilar are, how they differ from one another, what you need to know when speaking with your healthcare provider and more.


PRESENTERS

Teri Charrois

Teri Charrois

BScPharm, ACPR, MSc, EdD
Dr. Teri Charrois is currently the Associate Dean of Practice Innovation and Professor of Teaching at UBC Faculty of Pharmaceutical Sciences. Dr. Charrois graduated with her BScPharm from the University of Alberta (UofA) and then went on to complete an accredited pharmacy residency program followed by working as an internal medicine pharmacist before finishing her master’s degree in clinical epidemiology. In 2014, she joined the UofA Faculty of Pharmacy and Pharmaceutical Sciences as Academic Lead of Practice Innovation. During that time, she completed her Doctor of Education with a focus on adult learning and decision-making. Dr. Charrois was the first pharmacist in the Northern Alberta Osteoporosis Program and provides clinical care in the Multidisciplinary Bone Health Clinic with the Division of Rheumatology at the University of Alberta.

MODERATORS

Kerry Grady

Kerry Grady

MHSC, Senior Manager, Scientific and Clinical Programs, Osteoporosis Canada

STAY INFORMED

Get Osteoporosis updates, news and stories. We also inform you of upcoming events and live webinars, don’t miss out, join today!

OC REPLAY WEBINARS – RECENT ITEMS

 Biosimilar for Patients on Denosumab

This webinar will provide you with information about the recently approved biosimilar for denosumab by Health Canada. Join Dr. Teri Charrois who will discuss what a biologic and biosimilar are, how they differ from one another, what you need to know when speaking with your healthcare provider and more.

Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab

This webinar for healthcare providers will provide information specific to the Health Canada recently approved biosimilar for denosumab. Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment p…

Exercise Recommendations in the New Clinical Practice Guideline

The 2023 Clinical Practice Guideline on the Diagnosis and Management of Osteoporosis in Canada has key recommendations and good practice statements with emphasis on significant areas including exercise. Join Osteoporosis Canada as Dr. Lora Giangregorio shares information on physical activity and exercise for bone hea…
© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001